Omnia
Device
Nevro Corp.
Total Payments
$9.0M
Transactions
52,925
Doctors
15,428
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $2.6M | 298 | 28 |
| 2023 | $288,881 | 238 | 107 |
| 2022 | $3.0M | 30,809 | 11,535 |
| 2021 | $3.1M | 21,580 | 7,089 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.2M | 640 | 46.9% |
| Food and Beverage | $2.1M | 49,675 | 23.4% |
| Consulting Fee | $1.0M | 937 | 11.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $801,564 | 547 | 8.9% |
| Travel and Lodging | $585,487 | 899 | 6.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $141,769 | 100 | 1.6% |
| Education | $76,903 | 118 | 0.9% |
| Long term medical supply or device loan | $18,022 | 8 | 0.2% |
| Grant | $10,000 | 1 | 0.1% |
Payments by Type
General
$4.8M
52,285 transactions
Research
$4.2M
640 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PDN-Sensory | Nevro Corp. | $2.0M | 0 |
| Chronic Peripheral Polyneuropathy Randomized Trial | Nevro Corp. | $456,515 | 1 |
| Post Market Study | Nevro Corp. | $349,687 | 3 |
| RECHARGE II | Nevro Corp. | $303,158 | 0 |
| Post Market Observational Study | Nevro Corp. | $283,280 | 13 |
| PDN-PM | Nevro Corp. | $119,958 | 0 |
| Retrospective review of NSRBP outcomes and HCU | Nevro Corp. | $110,000 | 2 |
| CA2018-1 US RECHARGE | Nevro Corp. | $68,708 | 2 |
| T2D | Nevro Corp. | $66,761 | 0 |
| Prospective Pragmatic Multicenter Study | Nevro Corp. | $55,581 | 0 |
| Quantitative Functional Motion and Cognitive Monitoring Pre and Post Senza Spinal Cord Stimulator (SCS) Trial and Implantation Phases | Nevro Corp. | $40,760 | 1 |
| CA2018-2 US NSRBP | Nevro Corp. | $37,570 | 1 |
| Post-Market Multicenter Study Prospective | Nevro Corp. | $32,274 | 1 |
| Longitudinal Study Neuropathic Back Pain | Nevro Corp. | $31,300 | 0 |
| IDE Study | Nevro Corp. | $19,535 | 0 |
| Minimum Effective Dose | Nevro Corp. | $19,060 | 1 |
| Effect of 10kHz SCS therapy on Gastric Emptying and EGG in patients with Painful Gastroparesis | Nevro Corp. | $18,944 | 0 |
| HF SCS Autonomic Tone | Nevro Corp. | $18,802 | 0 |
| Prospective Observational Multicenter Study | Nevro Corp. | $18,408 | 1 |
| CA2022-1 US RECHARGE II | Nevro Corp. | $17,718 | 2 |
Top Doctors Receiving Payments for Omnia
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Kansas City, KS | $3.9M | 577 |
| , MD | Pain Medicine | Walnut Creek, CA | $184,541 | 186 |
| , MD | Neurological Surgery | Little Rock, AR | $178,802 | 134 |
| , M.D | Endocrinology, Diabetes & Metabolism | New York, NY | $116,894 | 105 |
| , M.D | Pain Medicine | Winston Salem, NC | $101,920 | 70 |
| , MD | Interventional Pain Medicine | Scottsdale, AZ | $101,574 | 157 |
| , M.D | Pain Medicine | Shrewsbury, NJ | $87,349 | 159 |
| , MD | Anesthesiology | Hammonton, NJ | $86,107 | 121 |
| , M.D | Pain Medicine | Roanoke, VA | $82,189 | 179 |
| , M.D | Anesthesiology | Toledo, OH | $79,748 | 116 |
| , M.D., MPH | Internal Medicine | Canton, GA | $78,879 | 127 |
| , M.D | Physical Medicine & Rehabilitation | Baltimore, MD | $70,574 | 126 |
| , DO | Anesthesiology | Rockford, IL | $69,743 | 123 |
| , DO | Anesthesiology | Knoxville, TN | $69,324 | 119 |
| , M.D | Pain Medicine | Kansas City, KS | $58,430 | 97 |
| , M.D | Pain Medicine | Scottsdale, AZ | $57,645 | 100 |
| , M.D | Pain Medicine | Vineyard, UT | $56,722 | 70 |
| , MD | Neurological Surgery | Thousand Oaks, CA | $52,257 | 110 |
| , M.D | Pain Medicine | Columbus, OH | $50,242 | 12 |
| , M.D | Pain Medicine | New Orleans, LA | $49,964 | 51 |
| , MD | Pain Medicine | Kansas City, KS | $49,221 | 79 |
| , M.D | Anesthesiology | Burnsville, MN | $49,089 | 69 |
| , MD PC | Pain Medicine | Reno, NV | $44,488 | 82 |
| , MD | Pain Medicine | Webster, TX | $42,191 | 57 |
| , D.O | Pain Medicine | Brunswick, GA | $41,657 | 86 |
Ad
Manufacturing Companies
- Nevro Corp. $9.0M
Product Information
- Type Device
- Total Payments $9.0M
- Total Doctors 15,428
- Transactions 52,925
About Omnia
Omnia is a device associated with $9.0M in payments to 15,428 healthcare providers, recorded across 52,925 transactions in the CMS Open Payments database. The primary manufacturer is Nevro Corp..
Payment data is available from 2021 to 2024. In 2024, $2.6M was paid across 298 transactions to 28 doctors.
The most common payment nature for Omnia is "Unspecified" ($4.2M, 46.9% of total).
Omnia is associated with 20 research studies, including "PDN-Sensory" ($2.0M).